CWM
NVCR icon

CIBC World Markets’s NovoCure NVCR Stock Holding History

CIBC World Markets’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$223K Sell
12,520
-11,111
-47% -$194K ﹤0.01% 1231
2025
Q1 		$421K Buy
23,631
+13,665
+137% +$310K ﹤0.01% 1090
2024
Q4 		$297K Buy
+9,966
New +$211K ﹤0.01% 940
2024
Q2 		– Sell
-59,432
Closed -$929K – 773
2024
Q1 		$929K Buy
+59,432
New +$874K 0.01% 652

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CIBC World Markets's NVCR Position: Q2 2025 in Review

CIBC World Markets reduced its NovoCure (NVCR) stake by 47% in Q2 2025, selling an estimated $194K and leaving 12,520 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #1231.

CIBC World Markets first reported a position in NVCR in Q1 2024 and has held it in 4 quarters since. The position peaked at $929K in Q1 2024. 242 funds tracked by Wall St. Rank hold NVCR as of Q2 2025.

  • CIBC World Markets held 12,520 shares of NovoCure worth $223K as of Q2 2025.
  • CIBC World Markets sold 11,111 NovoCure shares in Q2 2025, an estimated $194K.
  • NovoCure made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1231 holding.
  • CIBC World Markets first reported a position in NovoCure in Q1 2024 and has held it in 4 quarters since.
  • CIBC World Markets's NovoCure position peaked at $929K in Q1 2024.
  • 242 funds tracked by Wall St. Rank held NovoCure as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.